Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| MACROGENICS (NASDAQ: MGNX) | Delayed: 2.29 -1.34 (36.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.63 | 52 Week High | $36.11 | |||
| Open | $3.55 | 52 Week Low | $14.84 | |||
| Day High | $3.57 | P/E | 5.87 | |||
| Day Low | $2.27 | EPS | $0.39 | |||
| Volume | 2,142,216 | |||||
